Fallopian Tube Cancer
📧 Sign up to get email alerts when something new happens for Fallopian Tube Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer [Phase 1]
A Phase 1 trial evaluating the combination of gemcitabine and topotecan for refractory or recurrent ovarian cancer, fallopian tube cancer, o…
-
CLINICAL_TRIALS withdrawal · 2013-06-10Clinical Trial Update: Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin [Phase 2]
A Phase 2 trial of gemcitabine and carboplatin for persistent or recurrent ovarian epithelial cancer, fallopian tube cancer, or primary peri…
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 1]
A Phase 1 trial evaluating liposomal doxorubicin and etoposide in recurrent or persistent ovarian, fallopian tube, or primary peritoneal can…
-
CLINICAL_TRIALS trial_result · 2013-06-07Clinical Trial Update: Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer [Phase 2]
Phase 2 trial of an investigational Tarix Pharmaceuticals agent to reduce chemotherapy-induced thrombocytopenia in patients with ovarian, fa…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating a monoclonal antibody vaccine therapy for ovarian epithelial, fallopian tube, and primary peritoneal cancers has co…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian Women [Phase 2]
A Phase 2 trial evaluating pazopanib monotherapy after first-line chemotherapy in Asian women with ovarian, fallopian tube, or primary perit…
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial (CT-2103) evaluated CT-2103 in patients with recurrent ovarian epithelial cancer, fallopian tube cancer, or prima…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 1]
Phase 1 trial evaluating the combination of topotecan and etoposide in patients with recurrent ovarian, fallopian tube, or primary peritonea…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 1]
This is a Phase 1 study of a combination chemotherapy regimen in patients with untreated ovarian cancer, fallopian tube cancer, or primary p…
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial evaluating the combination chemotherapy plus peripheral stem cell transplantation in patients with Stage III/IV ovarian canc…
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer [Phase 2]
Phase 2 trial of amifostine for gynecologic cancers has been terminated (including ovarian, primary peritoneal, fallopian tube, cervical, ut…
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial of topotecan in unresectable gynecologic cancers has completed. The study included cervical, endometrial, fallopian tube, ovar…
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [Phase 3]
A Phase 3 trial comparing paclitaxel and carboplatin with or without epirubicin in stage IIB-IV invasive ovarian epithelial, fallopian tube,…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating cisplatin and gemcitabine in patients with refractory or recurrent ovarian epithelial, fallopian tube, or primary p…
-
CLINICAL_TRIALS trial_result · 2012-12-28Clinical Trial Update: PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer [Phase 1]
Phase I trial evaluating the SRC kinase inhibitor dasatinib in combination with paclitaxel and carboplatin for ovarian, peritoneal, and fall…
-
CLINICAL_TRIALS trial_result · 2012-11-29Clinical Trial Update: S9912 Combination Chemo in Stage III Ovarian Cancer, [Phase 2]
Phase 2 trial S9912 evaluated a combination chemotherapy regimen in stage III ovarian cancer; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-11-19Clinical Trial Update: A Phase I Study of Ovarian Cancer Peptides Plus GM-CSF and Adjuvant With Ovarian, Tubal or Peritoneal Cancer [Phase 1]
Phase I trial evaluating ovarian cancer peptides plus GM-CSF as adjuvant therapy for epithelial ovarian cancer, fallopian tube cancer, or pe…
-
CLINICAL_TRIALS trial_result · 2012-10-05Clinical Trial Update: ChemoFx® PRO - A Post-Market Data Collection Study
The post-market data collection study ChemoFx PRO by Precision Therapeutics has been terminated, with data collection across ovarian and rel…
-
CLINICAL_TRIALS trial_result · 2012-10-05Clinical Trial Update: Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer
This terminated clinical trial evaluated whether a chemoresponse assay correlates with progression-free survival in patients with recurrent …
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer [Phase 2]
Phase II trial evaluating the activity of pegaspargase in women with relapsed or refractory epithelial ovarian cancer, fallopian tube cancer…
-
CLINICAL_TRIALS trial_result · 2012-08-24Clinical Trial Update: S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer [Phase 2]
Phase 2 SWOG trial evaluating the combination of chemotherapy and surgery for stage III or IV ovarian cancer; results were posted after comp…
-
CLINICAL_TRIALS withdrawal · 2012-08-21Clinical Trial Update: Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer [Phase 2]
The Phase 2 trial of olaparib for recurrent BRCA-deficient ovarian cancer has been withdrawn (also related peritoneal and fallopian tube can…
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer [Phase 1]
Phase 1 trial evaluating PS-341 (bortezomib) in combination with carboplatin for platinum- and taxane-resistant recurrent ovarian cancer, pr…
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer [Phase 1, Phase 2]
A terminated Phase 1/2 trial evaluating PEG-interferon alfa-2b in platinum-resistant ovarian, fallopian tube, and peritoneal cancer.
-
CLINICAL_TRIALS trial_result · 2012-06-26Clinical Trial Update: Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
This Phase 2 trial evaluated vandetanib for ovarian, fallopian tube, and primary peritoneal cancers; the study was terminated and results we…